EntreMed IncAdd to My Watchlist

ENMD:USNASDAQ CMIndustry: Medical-Biomedical/Gene
  • 1.90
    Last
  • 0.04  -2.06%
    Today's Change
  • 1.94
    Previous Close
  • Today
     
    1.45
    2.38
    52 Week Low - High
8:10 pm ET 4/24/2014
Intraday data is at least 15 minutes delayed; All prices are in the local currency; Time is ET.
Stock Price Details
Shares Outstanding27 million
Market Cap$51 million
Return on Equity ttm-39.71%
Last DividendENMD:US does not pay a dividend
Earnings
EPS: Year Actual ttm-0.220
EPS: Year Est. ttm--
 
EPS: Quarterly Actual -0.05
EPS: Quarterly Est. --
 
Price/Earnings ttm--
Relative Price/Earnings--
Earnings Growth Rate71.79
Company Description
EntreMed, Inc. researches and develops biopharmaceutical products that focus on the role of blood and blood vessels in health and disease. The Company's products present antiangiogenic solutions to cancer, cardiovascular disease, and macular degeneration. Therapeutics currently being researched include Endostatin and Angiostatin.
Revenue$669,310
Net Income$-6 million
Total Assets$9 million
Employees7
Web Sitewww.entremed.com

Latest Headlines

No news available.

    Watchlist

    Unless indicated otherwise: intraday data is at least 15 minutes delayed; mutual fund NAVs are updated at the close of every market day; all prices are in the local currency; Time is ET.

    Sign In Now

     

    Not Registered?

    Get complete access to The Washington Post online - it's FREE!